Sun Pharma Drugs Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 20.00 Cr
- Company Age 12 Year, 8 Months
About Sun Pharma Drugs
Sun Pharma Drugs Private Limited (SPDPL) is Amalgamated company established on 31 Aug 2012 with its office registered at Mumbai, Maharashtra, India and has been running since 12 Year, 8 Months with a paid up capital of 20.00 Cr. According to MCA records, 3 Directors and 1 Signatories are linked to this company as of 18 Jan 2025.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74120MH2012PTC235214
- Company No.
235214
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Aug 2012
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Sun Pharma Drugs Private Limited
Explore comprehensive data for Sun Pharma Drugs Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Sun Pharma Drugs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhukar Ramdin  | Manager | 01-Sep-2012 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sailesh Desai | Director | 31-Aug-2012 | Current |
| Sudhir Valia | Director | 31-Aug-2012 | Current |
| Dilip Shanghvi | Director | 31-Aug-2012 | Current |
Financial Performance of Sun Pharma Drugs.
Enhance accessibility to Sun Pharma Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sun Pharma Drugs?
Unlock access to Sun Pharma Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Teknovace Wood Coatings Private LimitedSailesh Desai is a mutual person
Sun Pharmaceutical Industries LimitedSudhir Valia and Dilip Shanghvi are mutual person
Shantilal Shanghvi FoundationSailesh Desai, Sudhir Valia and 1 more are mutual person
Suraksha Asset Reconstruction LimitedSudhir Valia is a mutual person
Iti Housing Finance LimitedSudhir Valia is a mutual person
Sun Petrochemicals Private LimitedSailesh Desai, Sudhir Valia and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sun Pharma Drugs?
Unlock and access historical data on people associated with Sun Pharma Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sun Pharma Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sun Pharma Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Sun Pharma Drugs
Recent activity within the organization
- Director Appointment
Madhukar Krishnarao Ramdin was appointed as a Manager was appointed as a Manager on 01 Sep 2012 & has been associated with this company since 12 years 8 months .
- Director Appointment
Sailesh Trambaklal Desai was appointed as a Director was appointed as a Director on 31 Aug 2012 & has been associated with this company since 12 years 8 months .
- Director Appointment
Sudhir Vrundavandas Valia was appointed as a Director was appointed as a Director on 31 Aug 2012 & has been associated with this company since 12 years 8 months .
- Director Appointment
Dilip Shantilal Shanghvi was appointed as a Director was appointed as a Director on 31 Aug 2012 & has been associated with this company since 12 years 8 months .
- Company Incorporation
Sun Pharma Drugs Private Limited was registered on 31 Aug 2012 with Roc Mumbai & aged 12 years 8 months as per MCA records.
Recent News, Updates & Announcement
- Sun Pharma to buy remaining stake in Taro Pharma for $347.8 million. Details here | Mint.
Sun Pharmaceutical Industries plans to acquire all outstanding shares of Taro Pharmaceutical Industries for $43 per share in cash, aiming to gain complete control over its subsidiary.
- Sun Pharma inks pact with Bayer to sell drug for chronic kidney disease.
Sun Pharma has partnered up with Bayer to market Finerenone, a drug for chronic kidney disease, in India. Bayer grants non-exclusive rights to Sun Pharma to distribute Finerenone under the brand name Lyvelsa. Sun Pharma CEO emphasizes commitment to providing innovative medicines to Indian patients. .
Frequently asked questions
What is the Incorporation or founding date of Sun Pharma Drugs Private Limited?
Sun Pharma Drugs Private Limited was incorporated on 31 Aug 2012.
What is authorized share capital and paid-up capital of Sun Pharma Drugs Private Limited?
The authorized share capital of Sun Pharma Drugs Private Limited is ₹ 20.00 Cr and paid-up capital is ₹ 20.00 Cr.
Who are the current board members & directors of Sun Pharma Drugs Private Limited?
Currently 4 directors are associated with Sun Pharma Drugs Private Limited.
- Sailesh Trambaklal Desai
- Sudhir Vrundavandas Valia
- Dilip Shantilal Shanghvi
- Madhukar Krishnarao Ramdin
What is the registered address of Sun Pharma Drugs Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Sun Pharma Drugs Private Limited is Acme Plaza, Andheri Kurla Road (East) India, Mumbai, Maharashtra, 400059.
What is the corporate identification number (CIN) and company number of Sun Pharma Drugs Private Limited?
The corporate identification number (CIN) of Sun Pharma Drugs Private Limited is U74120MH2012PTC235214 and the company number is 235214 as per Ministry of Corporate Affairs (MCA).
What is the official website of Sun Pharma Drugs Private Limited?
The Official website of Sun Pharma Drugs Private Limited is https://www.sunpharma.com
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records